Home Cart Sign in  
Chemical Structure| 6398-98-7 Chemical Structure| 6398-98-7

Structure of Amodiaquine 2HCl Dihydrate
CAS No.: 6398-98-7

Chemical Structure| 6398-98-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Amodiaquine 2HCl is an inhibitor of histamine N-methyltransferase inhibitor with antimalarial and anti-inflammatory activities.

Synonyms: Amodiaquin dihydrochloride dihydrate; Amodiaquine dihydrochloride dihydrate

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Amodiaquine 2HCl Dihydrate

CAS No. :6398-98-7
Formula : C20H28Cl3N3O3
M.W : 464.81
SMILES Code : OC1=CC=C(NC2=CC=NC3=CC(Cl)=CC=C23)C=C1CN(CC)CC.[H]Cl.[H]Cl.[H]O[H].[H]O[H]
Synonyms :
Amodiaquin dihydrochloride dihydrate; Amodiaquine dihydrochloride dihydrate
MDL No. :MFCD09260307
InChI Key :YVNAYSHNIILOJS-UHFFFAOYSA-N
Pubchem ID :64646

Safety of Amodiaquine 2HCl Dihydrate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P261-P280-P305+P351+P338

Related Pathways of Amodiaquine 2HCl Dihydrate

epigenetics

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Human embryonic stem cell derived cortical neuron progenitor cells (hNPCs) 10 μM 3 days Amodiaquine inhibited ZIKV infection with an IC50 of 2.28 μM and blocked ZIKV-induced growth arrest or apoptosis. Cell Stem Cell. 2017 Aug 3;21(2):274-283.e5.
Primary striatal neurons 100 nM To test whether Nurr1 activation induces the molecular changes observed in the striatum of VPA mice. 100 nM AQ increased D2 expression levels in primary striatal neuron cultures of SAL mice but not VPA mice. Transl Psychiatry. 2022 Aug 9;12(1):324.
Primary striatal neurons 10 nM –10 μM 24 hours To evaluate cell viability and determine the optimal concentration without cytotoxicity. Concentrations >500 nM were significantly cytotoxic to primary striatal neurons. Transl Psychiatry. 2022 Aug 9;12(1):324.
SH-SY5Y cells 10 and 15 µM 24 hours To evaluate the effect of AQ on insulin-degrading enzyme (IDE) expression, AQ significantly increased IDE expression Aging Cell. 2019 Feb;18(1):e12866.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
SCID-beige mice ZIKV infection model Intraperitoneal injection 40 mg/kg/day Once daily for 7 days Amodiaquine significantly suppressed ZIKV infection in vivo, reducing ZIKV vRNA levels in the brain. Cell Stem Cell. 2017 Aug 3;21(2):274-283.e5.
BALB/c mice Prenatally VPA-exposed ASD mouse model Intraperitoneal injection 20 mg/kg Twice per day at 12 h intervals, for 2 weeks To investigate the effect of Nurr1 activation on behavior. AQ-injected SAL mice exhibited deficits in social interaction in the three-chamber test, increased motor learning rate in the rotarod test, and decreased mature spine density in the DMS. Transl Psychiatry. 2022 Aug 9;12(1):324.
Mice 5XFAD transgenic mouse model Intraperitoneal injection 20 mg/kg Twice daily for 2 weeks To evaluate the effect of AQ on AD pathological features, AQ significantly reduced Aβ plaque deposition, neuronal loss, microgliosis, and improved cognitive function Aging Cell. 2019 Feb;18(1):e12866.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.15mL

0.43mL

0.22mL

10.76mL

2.15mL

1.08mL

21.51mL

4.30mL

2.15mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories